One major pathogenic factor of Porphyromonas gingivalis is Arg-gingipain (Rgp), an arginine-specific cysteine proteinase. To clarify the effect of rgpA DNA vaccine, we immunized BALB/c mice via the abdomen with a Gene Gun or via the nasal cavity weekly for 6 weeks. After immunization, the mice were challenged orally with P. gingivalis. Immunization elicited IgG responses against P. gingivalis in both groups. Nasal immunization also induced sIgA against P. gingivalis, although Gene Gun immunization did not. Reduction of alveolar bone loss was observed in both groups at 42 days following initial infection. This effect was more pronounced in the intranasal immunization group than in the Gene Gun group. The results of this study suggest that immunization with rgpA DNA vaccine via the nasal cavity is an effective method for preventing alveolar bone loss incurred by infection with P. gingivalis.
Get full access to this article
View all access options for this article.
References
1.
Baker PJ, Evans RT, Roopenian DC (1994). Oral infection with Porphyromonas gingivalis and induced alveolar bone loss in immunocompetent and severe combined immunodeficient mice. Arch Oral Biol39:1035–1040.
2.
Booth V, Ashley FP, Lehner T (1996). Passive immunization with monoclonal antibodies against Porphyromonas gingivalis in patients with periodontitis. Infect Immun64:422–427.
3.
Curtis MA, Kuramitsu HK, Lantz M, Macrina FL, Nakayama K, Potempa J, et al. (1999). Molecular genetics and nomenclature of proteases of Porphyromonas gingivalis. J Periodontal Res34:464–472.
4.
Ebersole JL, Taubman MA, Smith DJ, Frey DE (1986). Human immune responses to oral microorganisms: patterns of systemic antibody levels to Bacteroides species. Infect Immun51:507–513.
5.
Genco CA, Odusanya BM, Potempa J, Mikolajczyk-Pawlinska J, Travis J (1998). A peptide domain on gingipain R which confers immunity against Porphyromonas gingivalis infection in mice. Infect Immun66:4108–4014.
6.
Gibson FC 3rd, Genco CA (2001). Prevention of Porphyromonas gingivalis-induced oral bone loss following immunization with gingipain R1. Infect Immun69:7959–7963.
7.
Gibson FC 3rd, Gonzalez DA, Wong J, Genco CA (2004). Porphyromonas gingivalis-specific immunoglobulin G prevents P. gingivalis-elicited oral bone loss in a murine model. Infect Immun72:2408–2411.
8.
Gonzalez D, Tzianabos AO, Genco CA, Gibson FC 3rd (2003). Immunization with Porphyromonas gingivalis capsular polysaccharide prevents P. gingivalis-elicited oral bone loss in a murine model. Infect Immun71:2283–2287.
9.
Goulet V, Britigan B, Nakayama K, Grenier D (2004). Cleavage of human transferrin by Porphyromonas gingivalis gingipains promotes growth and formation of hydroxyl radicals. Infect Immun72:4351–4356.
10.
Grenier D, Roy S, Chandad F, Plamondon P, Yoshioka M, Nakayama K, et al. (2003). Effect of inactivation of the Arg- and/or Lys-gingipain gene on selected virulence and physiological properties of Porphyromonas gingivalis. Infect Immun71:4742–4748.
11.
Houle MA, Grenier D, Plamondon P, Nakayama K (2003). The collagenase activity of Porphyromonas gingivalis is due to Arg-gingipain. FEMS Microbiol Lett221:181–185.
12.
Imamura T (2003). The role of gingipains in the pathogenesis of periodontal disease. J Periodontol74:111–118.
13.
Inagaki S, Ishihara K, Yasaki Y, Yamada S, Okuda K (2003). Antibody responses of periodontitis patients to gingipains of Porphyromonas gingivalis. J Periodontol74:1432–1439.
14.
Kawabata S, Terao Y, Fujiwara T, Nakagawa I, Hamada S (1999). Targeted salivary gland immunization with plasmid DNA elicits specific salivary immunoglobulin A and G antibodies and serum immunoglobulin G antibodies in mice. Infect Immun67:5863–5868.
Nakagawa T, Sims T, Fan Q, Potempa J, Travis J, Houston L, et al. (2001). Functional characteristics of antibodies induced by Arg-gingipain (HRgpA) and Lys-gingipain (Kgp) from Porphyromonas gingivalis. Oral Microbiol Immunol16:202–211.
17.
Potempa J, Sroka A, Imamura T, Travis J (2003). Gingipains, the major cysteine proteinases and virulence factors of Porphyromonas gingivalis: structure, function and assembly of multidomain protein complexes. Curr Protein Pept Sci4:397–407.
18.
Rajapakse PS, O’Brien-Simpson NM, Slakeski N, Hoffmann B, Reynolds EC (2002). Immunization with the RgpA-Kgp proteinase-adhesin complexes of Porphyromonas gingivalis protects against periodontal bone loss in the rat periodontitis model. Infect Immun70:2480–2486.
19.
Saito M, Otake S, Ohmura M, Hirasawa M, Takada K, Mega J, et al. (2001). Protective immunity to Streptococcus mutans induced by nasal vaccination with surface protein antigen and mutant cholera toxin adjuvant. J Infect Dis183:823–826.
20.
Socransky SS, Haffajee AD, Cugini MA, Smith C, Kent RLJ (1998). Microbial complexes in subgingival plaque. J Clin Periodontol25:134–144.
21.
Spellberg B, Edwards JE Jr (2001). Type 1/Type 2 immunity in infectious diseases. Clin Infect Dis32:76–102.
22.
Takeichi O, Haber J, Kawai T, Smith DJ, Moro I, Taubman MA (2000). Cytokine profiles of T-lymphocytes from gingival tissues with pathological pocketing. J Dent Res79:1548–1555.
23.
Taubman MA, Kawai T (2001). Involvement of T-lymphocytes in periodontal disease and in direct and indirect induction of bone resorption. Crit Rev Oral Biol Med12:125–135.
24.
Tew JG, Marshall DR, Moore WE, Best AM, Palcanis KG, Ranney RR (1985). Serum antibody reactive with predominant organisms in the subgingival flora of young adults with generalized severe periodontitis. Infect Immun48:303–311.
25.
Yonezawa H, Ishihara K, Okuda K (2001). Arg-gingipain A DNA vaccine induces protective immunity against infection by Porphyromonas gingivalis in a murine model. Infect Immun69:2858–2864.
26.
Yonezawa H, Kato T, Kuramitsu HK, Okuda K, Ishihara K (2005). Immunization by Arg-gingipain A DNA vaccine protects mice against an invasive Porphyromonas gingivalis infection through regulation of interferon-gamma production. Oral Microbiol Immunol20:259–266.
